Clinical Information

Head-to-Head Comparison of a Pulsatile and a Continuous Flow Left Ventricular Assist Device in High-Risk PCI Setting: iVAC2L Versus Impella 2.5. September 2019

Alexander Samol,1 Blerim Luani,2 Sven Kaese,3 Marcus Wiemer3 1Johannes Wesling University Hospital, Department of Cardiology and Critical Care Medicine, Minden, Germany; 2 Ruhr University Bochum, Minden, Germany; 3 Johannes Wesling University Hospital Minden, Minden, Germany Read here the full Jacc Publication B319.full Jacc Publication Ivac vs Impella

Head to head comparison of a pulsatile and a continuous flow left ventricular assist device in high-risk PCI setting – iVAC 2L vs. Impella

Head to head comparison of a pulsatile and a continuous flow left ventricular assist device in high-risk PCI setting – iVAC 2L vs. Impella Alexander Samol1, Stefanie Schmidt1, Blerim Luani1, Sven Kaese1, Melanie Zeyse1, Marcus Wiemer1 1Department of Cardiology and Critical Care Medicine, Johannes Wesling University Hospital, Minden, Germany Click to download study  EuroPCRposter Ivac Vs Impella

High-risk PCI under support of a pulsatile left ventricular assist device – first German experience with the iVAC 2L system

In 17 patients (3 female, age 73±9 years, left ventricular ejection fraction (LVEF) 45±12%) high-risk PCI (complex left main PCI n=8, PCI of last remaining vessel n=1, complex PCI in severe three-vessel disease and reduced LVEF n=8) was performed underuse of the iVAC 2L system, a new trans-femoral pulsatile assist device with up to 2l additional cardiac output. Before and after device placement as well as immediately after PCI aortic and intracoronary pressure data were collected Click Here for a full report – ivcdgk2018_16-9finalMAC  Click Here download publication – IVACTCTPOSTERWindows

First successful prevention of cardiopulmonary resuscitation during high-risk percutaneous coronary intervention by use of a pulsatile left ventricular assist device: baptismof fire of the iVAC 2L device

A case report published in “European Heart Journal” by Alexander Samol*, Stefanie Schmidt, Melanie Zeyse, and Marcus Wiemer Department of Cardiology and Critical Care Medicine, Johannes Wesling University Hospital, Ruhr University Bochum, Hans-Nolte-Str. 1, 32429 Minden, Germany Received 8 October 2017; accepted 2 January 2018 iVAC2L2 – case report 2 Germany